ロード中...
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
PURPOSE: Fluorouracil/leucovorin as the sole therapy for metastatic colorectal cancer (CRC) provides an overall survival of 8 to 12 months. With an increase in surgical resections of metastatic disease and development of new chemotherapies, indirect evidence suggests that outcomes for patients are i...
保存先:
主要な著者: | , , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
American Society of Clinical Oncology
2009
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2720081/ https://ncbi.nlm.nih.gov/pubmed/19470929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.20.5278 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|